Test Price
2,800 AED✅ Home Collection Available
MT-ND1 Gene Mitochondrial Complex I Deficiency Genetic Test in UAE
2,800 AED — 2026 DHA & MOHAP Compliant
تحليل جين MT-ND1 لنقص معقد الميتوكوندريا الأول في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary — ملخص تنفيذي
يقدم هذا التحليل الجيني المتطور تسلسلًا كاملاً لجين MT-ND1 باستخدام تقنية NGS للكشف عن الطفرات المسببة لنقص معقد الميتوكوندريا الأول، وهو معتمد من هيئة الصحة بدبي ومطابق لأحدث المعايير الدولية. يوفر التشخيص الدقيق للحالات العصبية والاستقلابية لدى البالغين والأطفال، مع خيار سحب العينة منزلياً ودعم استشارة ما بعد الفحص.
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified NGS pipeline with Sanger validation.
- ✓Premium Logistics: Paid hospital-grade home collection, ISO-certified cold‑chain transport, and VIP mobile phlebotomy service (8 AM – 11 PM).
- ✓Clinical Guidance: Complimentary telephonic post‑test clinical correlation session with a DHA-licensed molecular pathologist.
- ✓Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview — Diagnostic Precision for Mitochondrial Disorders
The MT-ND1 gene test employs deep next‑generation sequencing to identify pathogenic variants in the mitochondrial gene encoding subunit 1 of NADH dehydrogenase. It is the gold‑standard investigation for suspected mitochondrial complex I deficiency, a condition linked to Leigh syndrome, mitochondrial encephalomyopathy, and multisystem energy failure. (يُعد تحليل جين MT‑ND1 الفحص المرجعي لنقص المركب الأول في الميتوكوندريا المرتبط بمتلازمة لي واعتلال الدماغ العضلي.)
| Feature | Our MT-ND1 NGS Test | Closest Alternative (Targeted Panel) |
|---|---|---|
| Method | Full gene NGS + Sanger confirmation | Pre‑defined amplicons; may miss deep intronic or novel variants |
| Heteroplasmy Detection | Down to 1% heteroplasmy | Typically 5‑10%, missing low‑level mosaicism |
| Turnaround Time | 3‑4 Weeks | 4‑6 Weeks |
| Clinical Support | Post‑test genetic counselling included | Report only; additional consultation needed |
| UAE Compliance | DHA 9834453, ISO 9001:2015 | May not hold UAE‑specific certification |
Clinical Oversight & Safety — د. PRABHAKAR REDDY
“A positive MT‑ND1 result defines the molecular diagnosis but does not replace a thorough clinical evaluation. I emphasize that every variant must be interpreted alongside the patient’s neurological, cardiac, and metabolic phenotype. Never stop any prescribed medication or supplement regimen without direct consultation with your treating physician — mitochondrial patients often depend on precise metabolic support that must not be interrupted.” — Dr. PRABHAKAR REDDY, DHA License 61713011 (Clinical Pathologist & Molecular Geneticist)
Safety Warnings & Exclusion Criteria
- Exclusion Criteria: This test is not recommended for asymptomatic minors without informed consent from a legal guardian, as mandated by UAE CDS Law 2026 (Minor Protection). Testing in children requires a referral from a pediatric neurologist or medical geneticist.
- Do not self‑collect if: the patient has a bleeding disorder, severe needle phobia, or has experienced a vasovagal episode in the last 6 months. Home collection personnel are trained to recognize these risks and will escalate.
- Emergency Red Flags: Seek immediate medical attention if the patient exhibits acute metabolic decompensation — sudden lethargy, vomiting, seizures, or loss of consciousness — before or during the testing process. This test is not for acute crisis management.
- Medication Warning: Do not discontinue prescribed mitochondrial cofactors (e.g., Coenzyme Q10, riboflavin, L‑carnitine) in preparation for the test. Interruption may precipitate metabolic instability.
- Data Privacy: Genetic data is protected under UAE Federal Decree‑Law No. 41 of 2024 (Article 87) and the UAE Personal Data Protection Law. Your sample and results are pseudonymized and stored in a secure ISO‑certified biobank.
Pre‑test Requirements & Genetic Counselling
A mandatory genetic counselling session is provided to draw a detailed pedigree chart capturing all family members affected by mitochondrial complex I deficiency. This session ensures adequate understanding of autosomal/maternal inheritance, heteroplasmy, and the implications of results for blood relatives. For DNA extraction from blood, the patient must provide a clinical history form signed by the referring specialist (Neurologist, Medical Geneticist, or Clinical Biochemist).
Frequently Asked Questions — الأسئلة الشائعة
What does the MT-ND1 gene test detect, and how does NGS improve accuracy?
Snippet Answer: This test sequences the entire MT-ND1 mitochondrial gene to identify disease‑causing mutations responsible for complex I deficiency, including low‑level heteroplasmy that conventional methods miss.
Next‑generation sequencing reads every nucleotide multiple times, enabling detection of variants present in as few as 1% of mitochondrial DNA copies. This is critical for mitochondrial disorders where tissue‑specific heteroplasmy can mask the diagnosis. The methodology follows 2026 best‑practice guidelines with LC‑MS/MS cross‑validation where applicable.
هل يمكن استخدام بطاقة FTA لأخذ العينة من الأطفال الرضع في المنزل؟
الخلاصة: نعم، يمكن استخدام قطرة دم واحدة على بطاقة FTA لجمع العينة من الرضع والأطفال في المنزل دون الحاجة إلى سحب وريدي، مع مراعاة موافقة ولي الأمر.
تتيح تقنية FTA جمعًا غير مؤلم عبر وخز الكعب أو الإصبع، وتضمن استقرار الحمض النووي أثناء النقل في سلسلة التبريد المعتمدة من ISO. يُشترط وجود استشاري وراثة أطفال للتوقيع على نموذج الموافقة وفقًا لقانون CDS 2026.
How do I interpret a negative result when symptoms are highly suggestive?
Snippet Answer: A negative NGS result does not exclude mitochondrial disease; it may indicate variants in other genes, heteroplasmy below detection limit, or tissue‑specific mutations not present in blood.
In such cases, clinicians are advised to consider muscle biopsy or broader mitochondrial genome analysis. Our post‑ tele‑guidance reviews the complete clinical picture and may recommend follow‑up testing (e.g., whole mitochondrial genome NGS) at no additional counselling cost.
Call or WhatsApp for instant insurance check & home collection booking (8 AM – 11 PM daily).
Facility License: 9834453 | ISO 9001:2015 Cert: INT/EGQ/2509DA/3139 | Federal Decree‑Law No. 41 of 2024 (Art. 87) & UAE PDPL compliant. All genetic data handled with enterprise‑grade encryption.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians